1609358443_health-coronavirus-britain-vaccine.JPG

Health Canada waiting on more data before making a decision on AstraZeneca vaccine

Health Canada says it still needs more information before it can make a decision on the AstraZeneca-Oxford COVID-19 vaccine — news that came after the United Kingdom became the first country to authorize the vaccine.

In a statement released Wednesday, Canada’s independent regulator said it’s been reviewing the manufacturer’s vaccine information since Oct. 1 and as new data roll in.

“There is still information and data to be provided by AstraZeneca for review,” says the statement.

“Health Canada cannot provide a definite timeline for the completion of the review at this time.”

Earlier Wednesday, the U.K. announced the vaccine’s approval, with the health secretary saying rollout will start Jan. 4 in that country.

The AstraZeneca vaccine has been praised for its low cost and ease of use. Unlike other vaccines, it can be stored in refrigerators rather than ultra-cold storage units.

Canada, which has signed agreements to procure a range of vaccine candidates, has a deal with AstraZeneca for 20 million doses.

“Health Canada is working hard to give Canadians access to COVID-19 vaccines as quickly as possible without compromising its safety, efficacy and quality standards,” said the Health Canada statement.

“Protecting the health and safety of Canadians is a top priority.”

Health Canada has authorized two vaccines — the messenger RNA vaccines from Pfizer-BioNTech and Moderna Inc.


Source link

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email

Leave a Reply